Détention brevets de la classe C07D 233/26

Brevets de cette classe: 56

Historique des publications depuis 10 ans

6
5
3
2
7
5
4
2
2
0
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Propriétaires principaux

Proprétaire
Total
Cette classe
Theravance Biopharma R&D IP, LLC
461
10
B3ar Therapeutics, Inc.
17
5
Merck Patent GmbH
5850
3
F. Hoffmann-La Roche AG
7923
2
Massachusetts Institute of Technology
10019
2
Board of Regents, The University of Texas System
5754
2
President and Fellows of Harvard College
5952
2
The Board of Trustees of the University of Illinois
2686
2
Alzheon, Inc.
52
2
Arbutus Biopharma Corporation
177
2
The Arizona Board of Regents on Behalf of the University of Arizona
2145
2
H. Lee Moffitt Cancer Center and Research Institute, Inc.
933
2
Kyushu University, National University Corporation
1648
2
The Regents of the University of Colorado, a body corporate
2627
2
Sumitomo Metal Mining Co., Ltd.
1761
2
Agc, Inc.
4760
2
Inspirna, Inc.
38
2
University of Florida Research Foundation, Inc.
3994
1
Board of Trustees of Michigan State University
1178
1
Philera New Zealand Limited
14
1
Autres propriétaires 7